Daniel C. Martin insider trades: Deciphera Pharmaceuticals (DCPH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | DCPH | ↓ Sell | 2,267 | $15.62 | $35K | Direct | Feb 20, 2024 (4d) |
| Jan 16, 2024 | DCPH | ↓ Sell | 1,624 | $14.47 | $23K | Direct | Jan 18, 2024 (2d) |
| Dec 13, 2023 | DCPH | ↓ Sell | 1,727 | $15.37 | $27K | Direct | Dec 14, 2023 (1d) |
| Nov 30, 2023 | DCPH | ↓ Sell | 17,801 | $12.57 | $224K | Direct | Dec 1, 2023 (1d) |
| Oct 30, 2023 | DCPH | ↓ Sell | 1,407 | $12.02 | $17K | Direct | Oct 31, 2023 (1d) |
| Jun 16, 2023 | DCPH | ↓ Sell | 1,238 | $14.40 | $18K | Direct | Jun 21, 2023 (5d) |
| Feb 16, 2023 | DCPH | ↓ Sell | 1,159 | $15.10 | $17K | Direct | Feb 17, 2023 (1d) |
| Jan 17, 2023 | DCPH | ↓ Sell | 1,603 | $21.24 | $34K | Direct | Jan 19, 2023 (2d) |
| Jun 16, 2022 | DCPH | ↓ Sell | 1,311 | $10.75 | $14K | Direct | Jun 21, 2022 (5d) |
| Feb 16, 2022 | DCPH | ↓ Sell | 1,146 | $9.05 | $10K | Direct | Feb 18, 2022 (2d) |
| Jan 22, 2020 | DCPH | ↓ Sell | 26,999 | $67.18 | $1.8M | Direct | Jan 24, 2020 (2d) |
| Sep 19, 2019 | DCPH | ↓ Sell | 3,000 | $35.56 | $107K | Direct | Sep 23, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel C. Martin's insider trades
Daniel C. Martin is Chief Commercial Officer at Deciphera Pharmaceuticals (DCPH). Since Sep 19, 2019, Daniel has reported no open-market purchases and 12 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DCPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.